Product Information
METOPROLOL SUCC ER 100 MG TAB is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $0.0850 per EA under NDC 50742061701. Its NADAC has been published 446 times since Mar 21, 2018.
FDA first approved this application on Feb 6, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742061701
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METOPROLOL SUCCINATEApproval Type
Generic (ANDA)
FDA Application
ANDA204106FDA Approved
2/6/2018
TE Code
AB
On Market Since
2/6/2018
Pharmacological Classes
Price Statistics
The NADAC for METOPROLOL SUCC ER 100 MG TAB has been published 446 times since Mar 21, 2018, and over the history we have for it it has declined 76.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0850 per EA |
|---|---|
| All-time high | $0.3644 (Apr 11, 2018) |
| All-time low | $0.0813 (Apr 22, 2026) |
| 52-week high | $0.0966 |
| 52-week low | $0.0813 |
| Median price | $0.1522 |
| Average price | $0.1697 |
| Largest weekly change | +47.2% (Mar 20, 2024) |
| Weeks tracked | 446 |
| Tracking since | Mar 21, 2018 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Metoprolol succinate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METOPROLOL SUCC ER 100 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for METOPROLOL SUCC ER 100 MG TAB, manufactured by Ingenus Pharmaceuticals LLC, is $0.0850 per EA (NDC 50742061701), effective Sep 30, 2026.
How has the price of METOPROLOL SUCC ER 100 MG TAB changed over time?
Over the history we have for it, the NADAC for METOPROLOL SUCC ER 100 MG TAB has declined 76.7%. It has been tracked across 446 weekly CMS publications since Mar 21, 2018.
What are the highest and lowest recorded NADAC prices for METOPROLOL SUCC ER 100 MG TAB?
Since Mar 21, 2018, the NADAC for METOPROLOL SUCC ER 100 MG TAB has ranged from a low of $0.0813 (Apr 22, 2026) to a high of $0.3644 (Apr 11, 2018), with a median of $0.1522 per EA.
Are there cheaper alternatives to METOPROLOL SUCC ER 100 MG TAB?
10 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METOPROLOL SUCC ER 100 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures METOPROLOL SUCC ER 100 MG TAB?
METOPROLOL SUCC ER 100 MG TAB (NDC 50742061701) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.